Databricks Ups the Ante on OpenAI With New Language Model

Trending Companies

MedArrive, a provider of a mobile-enabled platform that allows healthcare professionals to extend care services at home, raises $8MM Equity Funding from Cobalt Ventures.

Health Care Technology • New York, NY • Post-Money Valuation

Recuro Health, a company that provides a suite of digital health offerings, analytics and services to empower patients along their entire health journeys, raises $47MM Series B from ARCH Venture Partners.

Digital Health • Richardson, TX • Post-Money Valuation

ImmuneBridge, a company that develops allogeneic immunotherapies for cancer, raises $12MM Seed from Insight Partners.

Biotechnology • San Francisco, CA • Post-Money Valuation

Absolute Labs, a company that developed a Web3 CRM and marketing engagement platform for Web2 brands and Web3 native companies, raises $8MM Seed from Aglae Ventures.

Blockchain • San Francisco, CA • Post-Money Valuation

Elevate, a developer of a consumer-directed benefits platform, raises $28MM Equity Funding from Anthemis.

SaaS • Denver, CO • Post-Money Valuation

CAT Labs, a firm that provides cybersecurity and digital asset recovery solutions, raises $4.3MM Pre-seed from Castle Island Ventures.

Cyber Security • Hollywood, FL • Post-Money Valuation

HUG, a company that developed a social curation and education platform for current and aspiring creators in Web3, raises $5MM Seed from DIGITAL.

NFT • New York, NY • Post-Money Valuation

Scene Health, a digital health company that provides medical adherence platform designed to improve the way patients take medication and engage with their providers, raises $17.7MM Series B from ABS Capital Partners.

Health Care Technology • Brooklandville, MD • Post-Money Valuation

VintaBio, a firm that provides cell and gene therapy manufacturing services, raises $64MM Equity Funding from Decheng Capital.

Health Care • Philadelphia, PA • Post-Money Valuation

Geneos Therapeutics, a company that develops personalized therapies for cancer using its GT-EPIC platform to target unique neoantigens from individual patient tumors, raises $5MM Series A-3 from 3B Future Health Fund.

Biotechnology • Plymouth Meeting, PA • Post-Money Valuation